Author:
Hari Parameswaran N.,Majhail Navneet S.,Zhang Mei-Jie,Hassebroek Anna,Siddiqui Fareeha,Ballen Karen,Bashey Asad,Bird Jenny,Freytes Cesar O.,Gibson John,Hale Gregaory,Holmberg Leona,Kamble Ram,Kyle Robert A.,Lazarus Hillard M.,LeMaistre Charles F.,Loberiza Fausto,Maiolino Angelo,McCarthy Philip L.,Milone Gustavo,Omondi Nancy,Reece Donna E.,Seftel Matthew,Trigg Michael,Vesole David,Weiss Brendan,Wiernik Peter,Lee Stephanie J.,Rizzo J. Douglas,Mehta Paulette
Subject
Transplantation,Hematology
Reference29 articles.
1. Epidemiology of the plasma-cell disorders;Kyle;Best Pract Res Clin Haematol,2007
2. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008
3. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders;Brown;Blood,2008
4. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among black and white veterans in the United States;Landgren;Blood,2006
5. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2005, based on November 2007 SEER data submission, posted to the SEER web site, 2008. last accessed January 2009.